Viewing Study NCT06460493


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-01-04 @ 9:32 PM
Study NCT ID: NCT06460493
Status: COMPLETED
Last Update Posted: 2025-04-18
First Post: 2024-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Ensifentrine Treatment on CAT Score
Sponsor: Verona Pharma plc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RPL554-CO-303
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View